Patents Assigned to Sanofi Pasteur, Ltd.
  • Monoclonal Antibodies and Uses Thereof
    Publication number: 20120295275
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: May 16, 2012
    Publication date: November 22, 2012
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Satsangi Singh Sandhu, Corey Lovitt, Artur Pedyczak, Scott Gallichan, Laszlo Radvanyi
  • SYSTEM AND PROCESS FOR PRODUCING MULTI-COMPONENT BIOPHARMACEUTICALS
    Publication number: 20110229517
    Abstract: A sterile, closed, disposable system for formulating biopharmaceutical compositions containing multiple active agents is described herein.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 22, 2011
    Applicant: SANOFI PASTEUR, LTD.
    Inventors: Kirsten Strahlendorf, Kevin Harper
  • Monoclonal Antibodies and Uses Thereof
    Publication number: 20110045502
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: July 14, 2010
    Publication date: February 24, 2011
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radvanyi
  • Monoclonal antibodies and uses thereof
    Publication number: 20080280309
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: February 8, 2007
    Publication date: November 13, 2008
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radavanyi